000 01705 a2200505 4500
005 20250513135408.0
264 0 _c19980414
008 199804s 0 0 eng d
022 _a0007-1188
024 7 _a10.1038/sj.bjp.0701597
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDavenport, A P
245 0 0 _aCharacterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.
_h[electronic resource]
260 _bBritish journal of pharmacology
_cJan 1998
300 _a223-30 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAorta
_xdiagnostic imaging
650 0 4 _aAutoradiography
650 0 4 _aBrain
_xdiagnostic imaging
650 0 4 _aCrotonates
_xmetabolism
650 0 4 _aDioxoles
_xmetabolism
650 0 4 _aDrug Stability
650 0 4 _aEndothelin Receptor Antagonists
650 0 4 _aEndothelin-1
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHeart Ventricles
_xdiagnostic imaging
650 0 4 _aHumans
650 0 4 _aIodine Radioisotopes
650 0 4 _aKidney
_xdiagnostic imaging
650 0 4 _aKinetics
650 0 4 _aLigands
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRadionuclide Imaging
650 0 4 _aRadiopharmaceuticals
_xmetabolism
650 0 4 _aReceptor, Endothelin A
650 0 4 _aReceptors, Endothelin
_xmetabolism
700 1 _aKuc, R E
700 1 _aAshby, M J
700 1 _aPatt, W C
700 1 _aDoherty, A M
773 0 _tBritish journal of pharmacology
_gvol. 123
_gno. 2
_gp. 223-30
856 4 0 _uhttps://doi.org/10.1038/sj.bjp.0701597
_zAvailable from publisher's website
999 _c9457768
_d9457768